Medikamentöse Behandlung primärer Hyperlipoproteinämien
- 1 February 1978
- journal article
- research article
- Published by Springer Nature in Klinische Wochenschrift
- Vol. 56 (3) , 99-110
- https://doi.org/10.1007/bf01478565
Abstract
No abstract availableKeywords
This publication has 129 references indexed in Scilit:
- A multivariate analysis of the risk of coronary heart disease in FraminghamPublished by Elsevier ,2004
- PORTACAVAL SHUNT IN HYPERLIPOPROTEINqMIAThe Lancet, 1973
- EFFECTS AND SIDE‐EFFECTS OF TREATMENT OF HYPERCHOLESTEROLEMIA WITH CHOLESTYRAMINE AND NEOMYCINActa Medica Scandinavica, 1973
- Secondary prevention trials using clofibrate: a joint commentary on the Newcastle and Scottish trials.BMJ, 1971
- Ischaemic Heart Disease: A Secondary Prevention Trial Using ClofibrateBMJ, 1971
- Inhibition of hepatic triglyceride formation by clofibrateJournal of Clinical Investigation, 1971
- Cholestyramine and nicotinic acid in the treatment of familial hyperbetalipoproteinaemia in the homozygous formAtherosclerosis, 1971
- Detection of individual susceptibility toward coronary diseaseProgress in Cardiovascular Diseases, 1971
- Reduction of Serum Cholesterol and Triglyceride Levels by the Combined Administration of Neomycin and ClofibrateCirculation, 1970
- Reduction of serum triglycerides and cholesterol by ethyl p-chlorophenoxyisobutyrate (CPIB)The American Journal of Cardiology, 1965